The Global Stem Cell Market- Growth, Trends, COVID-19 impact and Forecast (2021-2025)
The Stem Cell Market is segmented by Product type (Adult Stem cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells); Application, Technology; Geography (North America, Europe, APAC and ROW).
Introduction
Stem cells are undifferentiated cells that are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural and myocardial cells.
The Stem cell market is driven by factors such as increasing demand for biologics, technological advancement in stem cell therapeutics, and a growing focus on the development of personalized medicines.
The COVID-19 pandemic has severely impacted healthcare industry. During this period, most of the companies have been focusing on the development of cell-based therapies for COVID-19 treatment. Also, most of the pharmaceutical, biotechnology, and research institutes have been focusing on the development of stem cell therapy-based treatment against COVID-19.
Table of Contents
Executive Summary
Scope of the report
Research Methodology
Executive Summary
Introduction
5.1 Parent Market/ TAM
5.2 Market Outline
5.3 Market Segmentation
6.Five Force analysis
7.Market Sizing
8.Market segmentation
9.Geographical Landscape
9.1 APAC
9.2 Europe
9.3 North America
9.4 ROW
10.Growth drivers
10.1 Growing demand for stem cell banking
10.2 Rising prevalence of genetic disorders
11.Key Market Trends
12.Impact of Covid-19
13.Challenges
14.Customer Insights analysis
15.Major Market Players
15.1 CELGENE CORPORATION
15.2 ReNeuron Group
15.3 Virgin Health Bank
15.4 Biovault family
15.5 Caladrius
15.6 Mesoblast
15.7 Pluristem Therapeutics
15.8 Opexa Therapeutics
15.9 Seneca Biopharmaceuticals
15.10 Astellas Pharma
16.Recent Developments
17.Future Scope
18.Strategic Recommendations
Market Overview
The global Stem cell market is expected to grow to $20.30 billion by 2025.
Growth momentum is expected to accelerate during the forecast period with a 10.01% CAGR.
The growth of the market is attributed to the rising number of clinical trials and the growing adoption of stem cell therapies globally.
North America is dominating the market due to the presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms.
Key Trends
The gaining popularity of personalized medicines to promote stem cell market growth during the forecast period.
Due to the growing focus of stem cell-based research and the rising demand for novel treatments, the demand for stem cell in cancer therapies is expected to offer lucrative opportunities for the market near future.
Key Market Players
Some of the key players in the market are CELGENE CORPORATION, ReNeuron Group, Virgin Health Bank, Biovault family, Caladrius, Mesoblast.
The key players are evolving through various strategies such as investment in research and development, acquisitions, partnerships, and collaboration to secure the market position.
Growth Drivers and Challenges
Growing demand for stem cell banking is key driving factor of the market.
Rising prevalence of genetic disorders is also driving the market growth.
Increasing clinical trials for stem cell based-therapies is fuelling the market growth